Renalytix (Reg S) (RENX)

Sector:

Health Care

Index:

FTSE AIM All-Share

9.50p
   
  • Change Today:
      0.50p
  • 52 Week High: 50.40
  • 52 Week Low: 6.75
  • Currency: UK Pounds
  • Shares Issued: 189.93m
  • Volume: 708,027
  • Market Cap: £18.04m
  • RiskGrade: 348
  • Beta: 1.48

Latest Deals

Traded Action Notifier PriceAmountValue
10-Dec-24 Buy James Renwick McCullough 8.50p 25,000 £2,125.00
05-Dec-24 Buy Christopher H B Mills 7.00p 48,601 £3,402.07
05-Dec-24 Buy James Renwick McCullough 7.50p 53,300 £3,997.50

Largest Deals (28 days)

Traded Action Notifier PriceAmountValue
05-Dec-24 Buy James Renwick McCullough 7.50p 53,300 £3,997.50
05-Dec-24 Buy Christopher H B Mills 7.00p 48,601 £3,402.07
10-Dec-24 Buy James Renwick McCullough 8.50p 25,000 £2,125.00

Director Shareholdings

Notifier Holding Value*
Christopher H B Mills 14,658,547 £1,392,562
James Renwick McCullough 3,242,096 £307,999
Fergus Fleming 569,481 £54,101

Major Shareholders

Notifier** Holding Value*
CVI Holdings, LLC 33,000,000 £3,135,000
Ruffer LLP 28,500,000 £2,707,500
Unicorn Asset Management Limited 18,955,777 £1,800,799
Harwood Capital LLP 14,609,946 £1,387,945
Polar Capital, LLP 13,866,061 £1,317,276
Icahn School of Medicine at Mount Sinai 10,750,926 £1,021,338
Jefferson River Capital LLC 8,294,932 £788,018
Mount Sinai 8,018,986 £761,804
Gilder Gagnon Howe and Co LLC 6,042,634 £574,050
Forest Nominees Limited 4,001,187 £380,113
Lombard Odier & Co Ltd 2,952,334 £280,472
Amati Global Investors 2,455,247 £233,248
Fidelity Investment International 2,173,851 £206,516

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

RENX Market Data

Currency UK Pounds
Share Price 9.50p
Change Today 0.50p
% Change 5.56 %
52 Week High 50.40
52 Week Low 6.75
Volume 708,027
Shares Issued 189.93m
Market Cap £18.04m
Beta 1.48
RiskGrade 348

RENX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
15.83% above the market average15.83% above the market average15.83% above the market average15.83% above the market average15.83% above the market average
60.00% above the sector average60.00% above the sector average60.00% above the sector average60.00% above the sector average60.00% above the sector average
Price Trend
85.96% below the market average85.96% below the market average85.96% below the market average85.96% below the market average85.96% below the market average
83.78% below the sector average83.78% below the sector average83.78% below the sector average83.78% below the sector average83.78% below the sector average
Income Not Available
Growth
34.55% below the market average34.55% below the market average34.55% below the market average34.55% below the market average34.55% below the market average
50% below the sector average50% below the sector average50% below the sector average50% below the sector average50% below the sector average

RENX Dividends

No dividends found

Trades for 12-Dec-2024

Time Volume / Share Price
15:35 5,236 @ 9.32p
15:32 5,236 @ 9.32p
15:02 7,500 @ 9.32p
12:36 8,686 @ 9.00p
12:14 27,000 @ 9.14p

RENX Key Personnel

CEO James Renwick McCullough

Top of Page